Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
By Showngo66 in News
Updated 3 years ago
A two-dose version of Johnson & Johnson's coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday -- making a two-dose regimen of J&J's Janssen vaccine comparable to a two-dose regimen of Moderna's or Pfizer's.